Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Base value in index level serves as an anchor point for comparisons across periods, clarifying gains, losses, and scale.
23,806 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
As economies slow, shoppers pivot toward essentials and value. This article dives into whether walmart recession-proo...
Hormel (HRL) 2026 earnings continue to show resilience in a volatile consumer environment. This deep dive breaks down...
As rates normalize and demand stays steady, the current moment offers a rare blend of yields and reliability. This gu...
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Meta Platforms is navigating a bold AI infrastructure push that could redefine profits. This guide breaks down the ri...
FRP Holdings delivered a resilient Q3 2024 performance across its diversified subsidiaries. This deep dive reviews th...
Gorilla's Q1 2026 results shed light on the company’s growth trajectory and profitability path. This deep dive breaks...
When a CEO sells a sizable stake, investors take notice. This deep dive looks at what sentinelone stock sell after si...
IBP's Q1 2026 results set the tone for the year. This original analysis breaks down the numbers, margins, and guidanc...
A single stock in the AI conversation may be quietly delivering outsized, long-term gains. Learn why this Magnificent...
A surprising 90% rally in a little-known healthcare stock has investors asking what comes next. This guide breaks dow...